Study on the Mechanism of Budesonide in the Treatment of IgA Nephropathy Based on Network Pharmacology

Background IgA nephropathy (IgAN) is the most common primary glomerulonephritis in China and worldwide, approximately 25%-30% of patients will progress to end-stage renal disease within 20 years after diagnosis. Currently, there is no effective and safe treatment specifically for IgAN. In recent yea...

Celý popis

Podrobná bibliografie

Hlavní autor:	ZHANG Kang, ZHAO Tingting, ZHANG Bo, GAO Mengqi, LI Yuxi, WANG Shaopeng, ZHAO Wenjing
Médium:	Artigo
Jazyk:	Chinês
Vydáno:	Chinese General Practice Publishing House Co., Ltd 2023-12-01
Edice:	Zhongguo quanke yixue
Témata:	budesonide|glomerulonephritis, iga|iga nephropathy|network pharmacology|signaling pathway
On-line přístup:	https://www.chinagp.net/fileup/1007-9572/PDF/20230299.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!